Iris Francesconi

Iris has over 10 years of biopharmaceutical industry experience both in the United States and abroad. Most recently, Iris served as the head of marketing, market research, and commercial assessments at BioXcel Therapeutics. Prior to BioXcel, Iris led multiple U.S. therapeutics franchises including neurology, cardiology, gastro-enterology, and infection diseases at Allergan (now Abbvie). Before transitioning to the US organization, she also oversaw the regional and country level portfolio strategy for all regions globally. Iris transitioned to the biopharmaceutical industry via two years in strategy consulting. Iris started her professional career in the investment industry where she spent 10 years initially as a sell-side equity analyst and subsequently as a buy-side portfolio manager always focused on U.S and international biotechnology and life sciences platform companies of all market capitalizations.

Iris holds an M.B.A from Cornell University, a Ph.D. in Organic Chemistry from Georgia State University, and an M.S. and B.S. in Technical Chemistry from the University of Technology Graz, Austria.